· -Ramig, L., Sapir, S., Countryman, S., Pawlas, A., O’Brien, C., Hoehn, M.,Thompson, L. (2001). Intensive voice treatment (LSVT) for individuals with Parkinson disease: a two year follow-up. J, Neurology, Neurosurgery and Psychiatry, 71, 493-498.
· -Ramig, L., Sapir, S., Fox, C., & Countryman, S. (2001). Changes in vocal intensity following intensive voice treatment (LSVT) in individuals with Parkinson disease: a comparison with untreated patients and normal agematched controls. ovement Disorders, 16, 79-83.
· -Sapir, S., Ramig, L., Fox, C. (2011). Intensive voice treatment in Parkinson’s disease: Lee Silverman Voice Treatment (LSVT). Expert Reviews in Neurotherapeutics, 11(6), 815-810.
· -Liotti, M., Vogel, D., Ramig, L., New, P., Cook, C., Ingham, R., Ingham, J., & Fox, P. (2003). Hypophonia in Parkinson’s disease: neural correlation of voice treatment revealed by PET. Neurology, 60, 432-440.
· -Narayana, S., Fox, P., Zhang, W., Franklin, C., Robin, D., Vogel, D., Ramig, L. (2010). Neural correlates of efficacy of voice therapy in Parkinson’s disease identified by performance-correlation analysis. Human Brain Mapping, 31, 222-236.
· -Fox, C., & Boliek, C. (2012). Intensive voice treatment (LSVT LOUD) for children with spastic cerebral palsy and dysarthria. J. Speech Language Hearing Research, 55, 930-945.
· -Halpern, A., Ramig, L., Matos, C., Petska-Cable, J., Spielman, J., Pogoda, J., Gilley, P., Sapir, S., Bennett, J., McFarland, D. (2012). Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease. Am. J. Speech-Language Pathology, 21 (4), 354-367.